- Home
- NSP vs RNA Comparison
NSP vs RNA Comparison
Compare NSP & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSP
- RNA
- Stock Information
- Founded
- NSP 1986
- RNA 2012
- Country
- NSP United States
- RNA United States
- Employees
- NSP N/A
- RNA N/A
- Industry
- NSP Professional Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- NSP Consumer Discretionary
- RNA Health Care
- Exchange
- NSP Nasdaq
- RNA Nasdaq
- Market Cap
- NSP 3.2B
- RNA 3.4B
- IPO Year
- NSP 1997
- RNA 2020
- Fundamental
- Price
- NSP $65.95
- RNA $27.87
- Analyst Decision
- NSP Hold
- RNA Strong Buy
- Analyst Count
- NSP 4
- RNA 12
- Target Price
- NSP $89.67
- RNA $68.25
- AVG Volume (30 Days)
- NSP 549.1K
- RNA 1.4M
- Earning Date
- NSP 04-29-2025
- RNA 05-08-2025
- Dividend Yield
- NSP 3.60%
- RNA N/A
- EPS Growth
- NSP N/A
- RNA N/A
- EPS
- NSP 1.65
- RNA N/A
- Revenue
- NSP $6,642,000,000.00
- RNA $8,927,000.00
- Revenue This Year
- NSP $5.91
- RNA N/A
- Revenue Next Year
- NSP $7.79
- RNA $135.33
- P/E Ratio
- NSP $40.28
- RNA N/A
- Revenue Growth
- NSP 1.90
- RNA N/A
- 52 Week Low
- NSP $61.54
- RNA $21.51
- 52 Week High
- NSP $106.69
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- NSP 30.43
- RNA 45.31
- Support Level
- NSP $64.31
- RNA $25.58
- Resistance Level
- NSP $67.36
- RNA $33.62
- Average True Range (ATR)
- NSP 2.84
- RNA 2.09
- MACD
- NSP -0.60
- RNA -0.29
- Stochastic Oscillator
- NSP 23.29
- RNA 28.53
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.